Marika K. Iwane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marika K. Iwane has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Caroline B. Hall
3 shared publications- Geoffrey A. Weinberg
Department of Pediatrics, University of Rochester School of Medicine and Dentistry , Rochester, New York
3 shared publications Kathryn M. Edwards
3 shared publicationsMarie R. Griffin
3 shared publicationsPeter G. Szilagyi
3 shared publicationsCharmaine Coulen
2 shared publications
Latest Publications
- Open Access
- 21 November 2013
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 208 (suppl 3) , S165-S166
Importance of Global Surveillance for Respiratory Syncytial Virus
This supplement of the Journal provides a compendium of epidemiologic, clinical, and laboratory data to address gaps in knowledge regarding acute respiratory illness associated with respiratory syncytial virus (RSV) in countries participating in the International Emerging Infections Program and the Influenza Program of the Global Disease Detection (GDD) network of the US Centers for Disease Control and Prevention, Center for Global Health. The GDD network is described in the supplement review articles by Breiman et al and Fields et al. Six GDD Centers (in China, Guatemala, Egypt, Kenya, South Africa, and Thailand) present supplement articles about children and adults with community-acquired RSV infection confirmed by sensitive real-time reverse-transcription polymerase chain reaction (RT-PCR) assays during recent years of active, prospective, population-based surveillance for acute respiratory illness and severe lower respiratory tract infections; a seventh GDD Center, in Bangladesh, provided RSV seasonality data. These countries are classified as low- and middle-income economies by the World Bank and include populations considered at high risk for infectious diseases, including urban poor, rural, and human immunodeficiency virus (HIV)–infected persons. The GDD data underscore the need to develop public health and preventive strategies to mitigate the influence of RSV worldwide.
- 21 November 2013
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 208 (suppl 3) , S165-S166
Open AccessImportance of Global Surveillance for Respiratory Syncytial Virus
This supplement of the Journal provides a compendium of epidemiologic, clinical, and laboratory data to address gaps in knowledge regarding acute respiratory illness associated with respiratory syncytial virus (RSV) in countries participating in the International Emerging Infections Program and the Influenza Program of the Global Disease Detection (GDD) network of the US Centers for Disease Control and Prevention, Center for Global Health. The GDD network is described in the supplement review articles by Breiman et al and Fields et al. Six GDD Centers (in China, Guatemala, Egypt, Kenya, South Africa, and Thailand) present supplement articles about children and adults with community-acquired RSV infection confirmed by sensitive real-time reverse-transcription polymerase chain reaction (RT-PCR) assays during recent years of active, prospective, population-based surveillance for acute respiratory illness and severe lower respiratory tract infections; a seventh GDD Center, in Bangladesh, provided RSV seasonality data. These countries are classified as low- and middle-income economies by the World Bank and include populations considered at high risk for infectious diseases, including urban poor, rural, and human immunodeficiency virus (HIV)–infected persons. The GDD data underscore the need to develop public health and preventive strategies to mitigate the influence of RSV worldwide.
- Open Access
- 22 February 2013
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 177 (7) , 656-665
Disparities Between Black and White Children in Hospitalizations Associated With Acute Respiratory Illness and Laboratory-confirmed Influenza and Respiratory Syncytial Virus in 3 US Counties--2002-2009
Few US studies have assessed racial disparities in viral respiratory hospitalizations among children. This study enrolled black and white children under 5 years of age who were hospitalized for acute respiratory illness (ARI) in 3 US counties during October–May 2002–2009. Population-based rates of hospitalization were calculated by race for ARI and laboratory-confirmed influenza and respiratory syncytial virus (RSV), using US Census denominators. Relative rates of hospitalization between racial groups were estimated. Of 1,415 hospitalized black children and 1,824 hospitalized white children with ARI enrolled in the study, 108 (8%) black children and 111 (6%) white children had influenza and 230 (19%) black children and 441 (29%) white children had RSV. Hospitalization rates were higher among black children than among white children for ARI (relative rate (RR) = 1.7, 95% confidence interval (CI): 1.6, 1.8) and influenza (RR = 2.1, 95% CI: 1.6, 2.9). For RSV, rates were similar among black and white children under age 12 months but higher for black children aged 12 months or more (for ages 12–23 months, RR = 1.7, 95% CI: 1.1, 2.5; for ages 24–59 months, RR = 2.2, 95% CI: 1.3, 3.6). Black children versus white children were significantly more likely to have public insurance or no insurance (85% vs. 43%) and a history of asthma/wheezing (28% vs. 18%) but not more severe illness. The observed racial disparities require further study.
- 22 February 2013
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 177 (7) , 656-665
Open AccessDisparities Between Black and White Children in Hospitalizations Associated With Acute Respiratory Illness and Laboratory-confirmed Influenza and Respiratory Syncytial Virus in 3 US Counties--2002-2009
Few US studies have assessed racial disparities in viral respiratory hospitalizations among children. This study enrolled black and white children under 5 years of age who were hospitalized for acute respiratory illness (ARI) in 3 US counties during October–May 2002–2009. Population-based rates of hospitalization were calculated by race for ARI and laboratory-confirmed influenza and respiratory syncytial virus (RSV), using US Census denominators. Relative rates of hospitalization between racial groups were estimated. Of 1,415 hospitalized black children and 1,824 hospitalized white children with ARI enrolled in the study, 108 (8%) black children and 111 (6%) white children had influenza and 230 (19%) black children and 441 (29%) white children had RSV. Hospitalization rates were higher among black children than among white children for ARI (relative rate (RR) = 1.7, 95% confidence interval (CI): 1.6, 1.8) and influenza (RR = 2.1, 95% CI: 1.6, 2.9). For RSV, rates were similar among black and white children under age 12 months but higher for black children aged 12 months or more (for ages 12–23 months, RR = 1.7, 95% CI: 1.1, 2.5; for ages 24–59 months, RR = 2.2, 95% CI: 1.3, 3.6). Black children versus white children were significantly more likely to have public insurance or no insurance (85% vs. 43%) and a history of asthma/wheezing (28% vs. 18%) but not more severe illness. The observed racial disparities require further study.
- Open Access
- 19 October 2011
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 204 (11) , 1702-1710
Human Rhinovirus Species Associated With Hospitalizations for Acute Respiratory Illness in Young US Children
Background. The contribution of human rhinovirus (HRV) to severe acute respiratory illness (ARI) is unclear. Objective. To assess the association between HRV species detection and ARI hospitalizations. Methods. Children Results. A total of 1867 children with 1947 ARI hospitalizations and 784 controls with 790 clinic visits were enrolled and tested for HRV. The HRV-A detection rate among participants ≥24 months old was 8.1% in the hospitalized group and 2.2% in the control group (P = .009), and the HRV-C detection rates among those ≥6 months old were 8.2% and 3.9%, respectively (P = .002); among younger children, the detection rates for both species were similar between groups. The HRV-B detection rate was ≤1%. A broad diversity of HRV types was observed in both groups. Clinical presentations were similar among HRV species. Compared with children infected with other viruses, children with HRV detected were similar for severe hospital outcomes and more commonly had histories or diagnoses of asthma or wheezing. Conclusions. HRV-A and HRV-C were associated with ARI hospitalization and serious illness outcomes.
- 19 October 2011
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 204 (11) , 1702-1710
Open AccessHuman Rhinovirus Species Associated With Hospitalizations for Acute Respiratory Illness in Young US Children
Background. The contribution of human rhinovirus (HRV) to severe acute respiratory illness (ARI) is unclear. Objective. To assess the association between HRV species detection and ARI hospitalizations. Methods. Children Results. A total of 1867 children with 1947 ARI hospitalizations and 784 controls with 790 clinic visits were enrolled and tested for HRV. The HRV-A detection rate among participants ≥24 months old was 8.1% in the hospitalized group and 2.2% in the control group (P = .009), and the HRV-C detection rates among those ≥6 months old were 8.2% and 3.9%, respectively (P = .002); among younger children, the detection rates for both species were similar between groups. The HRV-B detection rate was ≤1%. A broad diversity of HRV types was observed in both groups. Clinical presentations were similar among HRV species. Compared with children infected with other viruses, children with HRV detected were similar for severe hospital outcomes and more commonly had histories or diagnoses of asthma or wheezing. Conclusions. HRV-A and HRV-C were associated with ARI hospitalization and serious illness outcomes.
- 1 May 2007
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 13 (3) , 307-313
Assessing Influenza Vaccine Utilization in Physician Offices Serving Adult Patients
Influenza vaccination among US adults has plateaued at suboptimal levels. Severe delays and shortages of influenza vaccine prompted revised guidances to prioritize vaccine first to persons at greatest risk for serious influenza complications and to create vaccine stockpiles. (1) Pilot an assessment of influenza vaccine use in a large sample of physician offices with adult patients. (2) Apply the method to assess vaccine receipt by age and risk groups. Influenza vaccination and risk status for the 2000-2001 season were obtained from record review conducted in November 2001 to April 2002 for adult patients in a sample of physicians' offices in eight states. Participating physicians also completed a questionnaire. The assessment method was feasible to implement. One hundred eighteen physicians participated. They administered more than 83 percent of doses to prioritized groups in October and November compared with 74 percent of doses during the entire season. Office-based vaccination coverage was less than 40 percent in all age and risk groups. More than 50 percent of participating physicians reported unused doses. Office-based assessments of vaccine utilization can be a valuable evaluation tool. Vaccine distribution was consistent with recommendations to target early vaccination to priority groups. Results highlight the difficulty distributing vaccine late in the season and the need for strategies to improve vaccination coverage, particularly when vaccine supply is inadequate.
- 1 May 2007
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 13 (3) , 307-313
Assessing Influenza Vaccine Utilization in Physician Offices Serving Adult Patients
Influenza vaccination among US adults has plateaued at suboptimal levels. Severe delays and shortages of influenza vaccine prompted revised guidances to prioritize vaccine first to persons at greatest risk for serious influenza complications and to create vaccine stockpiles. (1) Pilot an assessment of influenza vaccine use in a large sample of physician offices with adult patients. (2) Apply the method to assess vaccine receipt by age and risk groups. Influenza vaccination and risk status for the 2000-2001 season were obtained from record review conducted in November 2001 to April 2002 for adult patients in a sample of physicians' offices in eight states. Participating physicians also completed a questionnaire. The assessment method was feasible to implement. One hundred eighteen physicians participated. They administered more than 83 percent of doses to prioritized groups in October and November compared with 74 percent of doses during the entire season. Office-based vaccination coverage was less than 40 percent in all age and risk groups. More than 50 percent of participating physicians reported unused doses. Office-based assessments of vaccine utilization can be a valuable evaluation tool. Vaccine distribution was consistent with recommendations to target early vaccination to priority groups. Results highlight the difficulty distributing vaccine late in the season and the need for strategies to improve vaccination coverage, particularly when vaccine supply is inadequate.
- 1 June 2004
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 113 (6) , 1758-1764
Population-Based Surveillance for Hospitalizations Associated With Respiratory Syncytial Virus, Influenza Virus, and Parainfluenza Viruses Among Young Children
Objective. Respiratory syncytial virus (RSV), influenza virus, and parainfluenza viruses (PIV) cause significant morbidity in young children. Although only influenza virus infection and illness is currently vaccine-preventable, vaccines are under development for RSV and PIV. We established a prospective, active population-based surveillance network to provide precise estimates of hospitalization rates for viral acute respiratory illness (ARI) in young children and to measure the potential impact of enhanced vaccine usage on these rates. Methods. Prospective, active population-based surveillance was conducted in young children who were hospitalized for ARI from October 1, 2000, to September 30, 2001, in Monroe County, New York (Rochester area) and Davidson County, Tennessee (Nashville area). Eligible children younger than 5 years were those who resided in surveillance counties and were hospitalized for febrile or acute respiratory illness. Viral culture and polymerase chain reaction identified viruses from nasal and throat samples obtained from all surveillance children. We measured population-based rates of hospitalization for RSV, influenza virus, and PIV as well as demographic, clinical, and risk factor assessment for each virus. Results. Of 812 eligible hospital admissions, 592 (73%) children were enrolled. Of the enrolled children, RSV was identified in 20%, influenza in 3%, PIV in 7%, other respiratory viruses in 36%, and no detectable virus in 39%. Population-based rates of ARI hospitalizations in children younger than 5 years were 18 per 1000. Virus-positive hospitalization rates per 1000 children were 3.5 for RSV, 1.2 for PIV, and 0.6 for influenza virus. Younger age (particularly <1 year), black and Hispanic race/ethnicity, male gender, and presence of chronic underlying illness were associated with higher hospitalization rates. Conclusions. This study confirms that children younger than 5 years and particularly children younger than 1 year have a high burden of hospitalization from RSV, influenza, and PIV. The enhanced use of influenza vaccine and the development of RSV and PIV vaccines have the potential to reduce markedly the pediatric morbidity from ARIs.
- 1 June 2004
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 113 (6) , 1758-1764
Population-Based Surveillance for Hospitalizations Associated With Respiratory Syncytial Virus, Influenza Virus, and Parainfluenza Viruses Among Young Children
Objective. Respiratory syncytial virus (RSV), influenza virus, and parainfluenza viruses (PIV) cause significant morbidity in young children. Although only influenza virus infection and illness is currently vaccine-preventable, vaccines are under development for RSV and PIV. We established a prospective, active population-based surveillance network to provide precise estimates of hospitalization rates for viral acute respiratory illness (ARI) in young children and to measure the potential impact of enhanced vaccine usage on these rates. Methods. Prospective, active population-based surveillance was conducted in young children who were hospitalized for ARI from October 1, 2000, to September 30, 2001, in Monroe County, New York (Rochester area) and Davidson County, Tennessee (Nashville area). Eligible children younger than 5 years were those who resided in surveillance counties and were hospitalized for febrile or acute respiratory illness. Viral culture and polymerase chain reaction identified viruses from nasal and throat samples obtained from all surveillance children. We measured population-based rates of hospitalization for RSV, influenza virus, and PIV as well as demographic, clinical, and risk factor assessment for each virus. Results. Of 812 eligible hospital admissions, 592 (73%) children were enrolled. Of the enrolled children, RSV was identified in 20%, influenza in 3%, PIV in 7%, other respiratory viruses in 36%, and no detectable virus in 39%. Population-based rates of ARI hospitalizations in children younger than 5 years were 18 per 1000. Virus-positive hospitalization rates per 1000 children were 3.5 for RSV, 1.2 for PIV, and 0.6 for influenza virus. Younger age (particularly <1 year), black and Hispanic race/ethnicity, male gender, and presence of chronic underlying illness were associated with higher hospitalization rates. Conclusions. This study confirms that children younger than 5 years and particularly children younger than 1 year have a high burden of hospitalization from RSV, influenza, and PIV. The enhanced use of influenza vaccine and the development of RSV and PIV vaccines have the potential to reduce markedly the pediatric morbidity from ARIs.
- 1 June 2004
- Published by Elsevier in International Congress Series
- Vol. 1263, 644-648
Influenza vaccination encouraged for all children aged 6–23 months in the United States: vaccine supply and feasibility implications
- 1 June 2004
- Published by Elsevier in International Congress Series
- Vol. 1263, 644-648
Influenza vaccination encouraged for all children aged 6–23 months in the United States: vaccine supply and feasibility implications